Webinar – Biologics & Biosimilars

November 12, 2015

Watch this webinar on YouTube:

View the slides on Slideshare:

This webinar was titled What is a biosimilar? All you need to know about the current biologics and biosimilars landscape in Canada, and was presented by Karen Burke, Ph.D. of Amgen Canada, Inc. 
Webinar Information
The webinar is broken out into two parts:

Part 1:  Biologics – The first part of the presentation focused on biologics, including an explanation of the high level of precision that is required to produce a consistent biological product each time.

Part 2:  Biosimilars – The second part of the presentation focused on the growing interest in biosimilars, followed by what we can learn from Europe’s experience. Also provided were Health Canada’s position on biosimilars, discussion on key issues surrounding biosimilars relevant to the Canadian market, as well as, the importance of patient safety and patient choice.

Following the presentation, there was an interactive discussion where listeners had an opportunity to ask questions and continue the dialogue on biologic medicines and biosimilars.
Presenter Information
Karen A. Burke, Ph.D., is the Director of Regulatory Affairs at Amgen Canada Inc, a role she has held since 2006.  She is also interim Regulatory Affairs lead for Amgen’s Intercontinental Region. 

Since obtaining her Ph.D. in Organometallic Chemistry from McMaster University, Karen has worked in the pharmaceutical industry in several roles over a career of more than 20 years, including positions in Operations and in Regulatory Affairs at Astra Pharma/AstraZeneca Canada Inc.